INMBINmune Bio, Inc.

$38M

FY 2016 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$227,000

Net Income

-$277,000

EPS (Diluted)

$-0.05

Cash Flow

Operating Cash Flow

-$317,379

Free Cash Flow

-$317,379

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$451,607

Total Liabilities

$600,810

Stockholders' Equity

-$149,203

Cash & Equivalents

$141,659

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$227,000	-$48,868	-364.5%
Net Income	-$277,000	-$48,868	-466.8%

INMB FY 2016 Earnings — INmune Bio, Inc. Revenue & Financial Results | Market Cap Arena